Disclaimer. This site reads publicly available research papers and corporate filings and explains what they say. It is not investment advice and does not recommend buying or selling any security. Historical cases shown here are computed from public data; the sample sizes are small and are not a basis for prediction. We do not answer questions about individual stocks.
Readouts · Company page
Tonix Pharmaceuticals
Company facts
- Status
- NASDAQ TNXP
- Headquarters
- BERKELEY HEIGHTS, NJ
- Industry
- Pharmaceutical Preparations SIC 2834
- Fiscal year end
- 1231
- Links
- Filings · SEC · Quote · Yahoo
- Source
- SEC
Financial summary (from filings)
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Revenue | 8 | 10 | 13 |
| Operating income | −118 | −137 | −126 |
| Net income | −117 | −130 | −124 |
| Total assets | 154 | 163 | 277 |
| Total liabilities | 49 | 23 | 32 |
| Total equity | 106 | 140 | 245 |
Unit: USD million · Consolidated statements · Source SEC 10-K/20-F
Figures are copied from the filing with only the unit changed. No growth rates or assessments are shown.
Readouts that mention this company
Pharmaceutical filing citing an *Annals of Internal Medicine* paper — Tonix Pharmaceuticals, 2024-03-07 · Readout case C094
Pharmaceutical filing citing an American Journal of Transplantation paper — Tonix Pharmaceuticals, 2023-05-04 · Readout case C082
pharmaceutical filing citing a JAMA paper — Tonix Pharmaceuticals, 2024-11-13 · Readout case C111
pharmaceutical filing citing a New England Journal of Medicine paper — Tonix Pharmaceuticals, 2024-03-05 · Readout case C093
pharmaceutical filing citing MMWR Morbidity and Mortality Weekly Report paper — Tonix Pharmaceuticals, 2022-05-09 · Readout case C065
Pharmaceutical filing citing an American Journal of Transplantation paper — Tonix Pharmaceuticals, 2023-05-08 · Readout case C083
Pharmaceutical filing citing an American Journal of Transplantation paper — Tonix Pharmaceuticals, 2023-04-17 · Readout case C081
Pharmaceutical regulatory filing citing National Academies Press eBooks paper — Tonix Pharmaceuticals, 2024-07-08 · Readout case C102
Pharmaceutical regulatory filing citing a JCI Insight paper — Tonix Pharmaceuticals, 2022-01-04 · Readout case C058
Regulatory filing citing a Genome biology paper — Tonix Pharmaceuticals, 2020-12-23 · Readout case C036
Pharmaceutical regulatory filing citing a JAMA Network Open paper — Tonix Pharmaceuticals, 2025-01-08 · Readout case C113
pharmaceutical filing citing a JCI Insight paper — Tonix Pharmaceuticals, 2022-01-11 · Readout case C059
Pharmaceutical regulatory filing citing a JCI Insight paper — Tonix Pharmaceuticals, 2021-12-14 · Readout case C057
Regulatory filing citing a Brain Behavior and Immunity paper — Tonix Pharmaceuticals, 2022-06-07 · Readout case C067
Regulatory filing citing a Genome biology paper — Tonix Pharmaceuticals, 2020-12-04 · Readout case C035
pharmaceutical filing citing a New England Journal of Medicine paper — Tonix Pharmaceuticals, 2024-02-28 · Readout case C092
Regulatory filing citing a Cell paper — Tonix Pharmaceuticals, 2024-09-09 · Readout case C107
Pharmaceutical regulatory filing citing a PLoS ONE paper — Tonix Pharmaceuticals, 2018-01-22 · Readout case C009
Pharmaceutical filing citing a Psychiatry Research paper — Tonix Pharmaceuticals, 2024-02-12 · Readout case C090
Pharmaceutical regulatory filing citing a JCI Insight paper — Tonix Pharmaceuticals, 2021-11-23 · Readout case C055
Regulatory filing by Tonix Pharmaceuticals citing a paper in Nature Structural & Molecular Biology — Readout case C061, 2022-03-14
Cancer Cell paper cited in pharmaceutical regulatory filing — Tonix Pharmaceuticals, 2025-07-02 · Readout case C127
Pharmaceutical regulatory filing citing Cell paper — Tonix Pharmaceuticals, 2024-09-16 · Readout case C108
National R&D projects (NTIS)
No records
Korean patent filings (KIPRIS)
No records
Papers with affiliated authors (OpenAlex)
No records
Last updated 2026-09-21